Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-23-002390
Accepted
2023-08-16 00:15:09
Documents
1
Effectiveness Date
2023-08-15
Registration Form
POS AM
Reference AccNo
0001193125-23-210776

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 609
  Complete submission text file 9999999995-23-002390.txt   1725
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Filer) CIK: 0001821323 (see all company filings)

EIN.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-264296 | Film No.: 231176397
SIC: 2834 Pharmaceutical Preparations